Hong Kong Stock Spotlight | TYK Medicines-B (02410) Climbs Over 6% in Morning Trade as Half-Year Loss Narrows Sharply and TY-9591 Commercialization Ramps Up
Fund investors surprised as institutions sell into strength, with popular healthcare and medical ETFs seeing roughly 3 billion yuan in net outflows recently
Pharmaceutical Research Surpasses Semiconductor in Interest, Innovative Drug Sector Retreats, Huabao Fund's Hong Kong Biotech ETF Falls Below Key Moving Average, CXO Shows Resilience with WuXi Companies Rising Against the Trend